H. TAKAI

776 total citations
30 papers, 632 citations indexed

About

H. TAKAI is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, H. TAKAI has authored 30 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in H. TAKAI's work include Glycosylation and Glycoproteins Research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Quinazolinone synthesis and applications (4 papers). H. TAKAI is often cited by papers focused on Glycosylation and Glycoproteins Research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Quinazolinone synthesis and applications (4 papers). H. TAKAI collaborates with scholars based in Japan, United States and Italy. H. TAKAI's co-authors include Yuji Nomoto, Masami Suzuki, Kazuo Kubo, Atsuhiko Kato, Joji Nakamura, H. OBASE, Hiroyuki Nakayama, Kunio Doi, Keiichi Katayama and Koji Uetsuka and has published in prestigious journals such as Cancer Research, Biology of Reproduction and Vaccine.

In The Last Decade

H. TAKAI

28 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. TAKAI Japan 14 204 191 109 88 78 30 632
Kazuyo Mori Japan 10 637 3.1× 39 0.2× 84 0.8× 50 0.6× 76 1.0× 23 923
Xinqiang Li China 14 295 1.4× 28 0.1× 116 1.1× 22 0.3× 42 0.5× 32 591
Xiuming Yang China 13 391 1.9× 49 0.3× 24 0.2× 192 2.2× 23 0.3× 20 710
Julie Sanchez Australia 11 231 1.1× 37 0.2× 199 1.8× 11 0.1× 33 0.4× 19 498
Didier Ferbus France 15 610 3.0× 42 0.2× 179 1.6× 10 0.1× 43 0.6× 36 871
Ya-Hui Chang Taiwan 11 188 0.9× 40 0.2× 17 0.2× 40 0.5× 83 1.1× 45 579
Montserrat Nogueira Spain 14 214 1.0× 29 0.2× 169 1.6× 8 0.1× 79 1.0× 24 673
Nagma Khan United Kingdom 5 702 3.4× 113 0.6× 68 0.6× 5 0.1× 40 0.5× 8 829
M.S. Metcalfe United Kingdom 7 204 1.0× 17 0.1× 78 0.7× 23 0.3× 56 0.7× 9 519
Carol E. Dowling United States 16 498 2.4× 38 0.2× 65 0.6× 6 0.1× 49 0.6× 24 1.2k

Countries citing papers authored by H. TAKAI

Since Specialization
Citations

This map shows the geographic impact of H. TAKAI's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. TAKAI with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. TAKAI more than expected).

Fields of papers citing papers by H. TAKAI

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. TAKAI. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. TAKAI. The network helps show where H. TAKAI may publish in the future.

Co-authorship network of co-authors of H. TAKAI

This figure shows the co-authorship network connecting the top 25 collaborators of H. TAKAI. A scholar is included among the top collaborators of H. TAKAI based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. TAKAI. H. TAKAI is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
TAKAI, H., et al.. (2018). A pediatric case of anaphylactic shock induced by tipepidine hibenzate (Asverin). Asia Pacific Allergy. 8(4). e37–e37.
2.
Yorita, Kenji, Nobuyasu Takahashi, H. TAKAI, et al.. (2010). Prognostic significance of circumferential cell surface immunoreactivity of glypican‐3 in hepatocellular carcinoma. Liver International. 31(1). 120–131. 48 indexed citations
3.
TAKAI, H., Atsuhiko Kato, Teruo Nakamura, et al.. (2010). The importance of characterization of FITC-labeled antibodies used in tissue cross-reactivity studies. Acta Histochemica. 113(4). 472–476. 11 indexed citations
4.
Ishiguro, Takahiro, Yasuko Kinoshita, Masamichi Sugimoto, et al.. (2010). Abstract 2426: Anti-Glypican3 antibody for treatment of human liver cancer. Cancer Research. 70(8_Supplement). 2426–2426. 2 indexed citations
5.
TAKAI, H., Takahiro Ishiguro, Hiromichi Terashima, et al.. (2009). Involvement of glypican-3 in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinoma. Cancer Biology & Therapy. 8(24). 2329–2338. 56 indexed citations
6.
TAKAI, H., Atsuhiko Kato, Chie Kato, et al.. (2009). The expression profile of glypican‐3 and its relation to macrophage population in human hepatocellular carcinoma. Liver International. 29(7). 1056–1064. 34 indexed citations
7.
TAKAI, H., Atsuhiko Kato, Takahiro Ishiguro, et al.. (2009). Optimization of tissue processing for immunohistochemistry for the detection of human glypican-3. Acta Histochemica. 112(3). 240–250. 18 indexed citations
8.
TAKAI, H., Atsuhiko Kato, Yasuko Kinoshita, et al.. (2009). Histopathological analyses of the antitumor activity of anti-glypican-3 antibody (GC33) in human liver cancer xenograft models: The essential role of macrophages. Cancer Biology & Therapy. 8(10). 930–938. 18 indexed citations
9.
Kato, Atsuhiko, Saori Matsuo, H. TAKAI, et al.. (2008). Early effects of tocilizumab on bone and bone marrow lesions in a collagen-induced arthritis monkey model. Experimental and Molecular Pathology. 84(3). 262–270. 31 indexed citations
10.
Kita, Yoko, Takaaki Tanaka, Satoshi Yoshida, et al.. (2005). Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model. Vaccine. 23(17-18). 2132–2135. 49 indexed citations
11.
Suzuki, Masami, H. TAKAI, Takeshi Watanabe, et al.. (2004). PLP-AMeX Method, Fixation Using PLP Fixative and Embedding in Paraffin by the AMeX Method, is Useful not only for Histochemistry but also In Situ Hybridization. Journal of Toxicologic Pathology. 17(3). 171–176. 4 indexed citations
12.
Adachi, Kenji, Masami Suzuki, Keigo Yorozu, et al.. (2003). Effects of Granulocyte Colony-Stimulating Factor (G-CSF) on Bleomycin-Induced Lung Injury of Varying Severity. Toxicologic Pathology. 31(6). 665–673. 20 indexed citations
13.
TAKAI, H., Keiichi Katayama, Akira Yasoshima, et al.. (2003). NMDA-induced apoptosis in the developing rat brain. Experimental and Toxicologic Pathology. 55(1). 33–37. 7 indexed citations
14.
Adachi, Kenji, Masami Suzuki, Keigo Yorozu, et al.. (2003). Effects of Granulocyte Colony-Stimulating Factor (G-CSF) on Bleomycin-Induced Lung Injury of Varying Severity. Toxicologic Pathology. 31(6). 665–673.
15.
Katayama, Keiichi, Masaki Ueno, H. TAKAI, et al.. (2002). Ethylnitrosourea Induces Apoptosis and Growth Arrest in the Trophoblastic Cells of Rat Placenta1. Biology of Reproduction. 67(2). 431–435. 27 indexed citations
16.
Nomoto, Yuji, et al.. (1991). Studies on cardiotonic agents. VI. Synthesis of novel 4,5-dihydro-3(2H)-pyridazinone derivatives carrying some benzoheterocycles at the 6-position.. Chemical and Pharmaceutical Bulletin. 39(2). 352–357. 13 indexed citations
17.
18.
Nomoto, Yuji, et al.. (1991). Studies on cardiotonic agents. VII. Potent cardiotonic agent KF15232 with myofibrillar Ca2+ sensitizing effect.. Chemical and Pharmaceutical Bulletin. 39(4). 900–910. 8 indexed citations
19.
Nomoto, Yuji, et al.. (1990). Studies on cardiotonic agents. II. Synthesis of novel phthalazine and 1,2,3-benzotriazine derivatives.. Chemical and Pharmaceutical Bulletin. 38(8). 2179–2183. 143 indexed citations
20.
Nomoto, Yuji, H. OBASE, H. TAKAI, et al.. (1990). Studies on cardiotonic agents. I. Synthesis of some quinazoline derivatives.. Chemical and Pharmaceutical Bulletin. 38(6). 1591–1595. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuyo Mori Breakdown of academic impact, for papers by Xinqiang Li Breakdown of academic impact, for papers by Xiuming Yang Breakdown of academic impact, for papers by Julie Sanchez Breakdown of academic impact, for papers by Didier Ferbus Breakdown of academic impact, for papers by Ya-Hui Chang Breakdown of academic impact, for papers by Montserrat Nogueira Breakdown of academic impact, for papers by Nagma Khan Breakdown of academic impact, for papers by M.S. Metcalfe Breakdown of academic impact, for papers by Carol E. Dowling
Rankless by CCL
2026